The global Antimicrobial Peptides market size was valued at US$ 5.7 million in 2024 and is forecast to a readjusted size of USD 8.1 million by 2031 with a CAGR of 5.3% during review period.
Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
By region, North America had the highest share of sales, at about 35%.
This report is a detailed and comprehensive analysis for global Antimicrobial Peptides market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Antimicrobial Peptides market size and forecasts, in consumption value ($ Million), sales quantity (Mg), and average selling prices (US$/Mg), 2020-2031
Global Antimicrobial Peptides market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Mg), and average selling prices (US$/Mg), 2020-2031
Global Antimicrobial Peptides market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Mg), and average selling prices (US$/Mg), 2020-2031
Global Antimicrobial Peptides market shares of main players, shipments in revenue ($ Million), sales quantity (Mg), and ASP (US$/Mg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antimicrobial Peptides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antimicrobial Peptides market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores, GenScript, Hycult Biotech, Sunsmile, Ruixing Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Antimicrobial Peptides market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides
麻豆原创 segment by Application
Pharmaceuticals
Feed Additives
Others
Major players covered
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antimicrobial Peptides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antimicrobial Peptides, with price, sales quantity, revenue, and global market share of Antimicrobial Peptides from 2020 to 2025.
Chapter 3, the Antimicrobial Peptides competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antimicrobial Peptides breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Antimicrobial Peptides market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antimicrobial Peptides.
Chapter 14 and 15, to describe Antimicrobial Peptides sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Antimicrobial Peptides Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Plant Antimicrobial Peptides
1.3.3 Microbial Antimicrobial Peptides
1.3.4 Animal Antimicrobial Peptides
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Antimicrobial Peptides Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pharmaceuticals
1.4.3 Feed Additives
1.4.4 Others
1.5 Global Antimicrobial Peptides 麻豆原创 Size & Forecast
1.5.1 Global Antimicrobial Peptides Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Antimicrobial Peptides Sales Quantity (2020-2031)
1.5.3 Global Antimicrobial Peptides Average Price (2020-2031)
2 Manufacturers Profiles
2.1 AnaSpec
2.1.1 AnaSpec Details
2.1.2 AnaSpec Major Business
2.1.3 AnaSpec Antimicrobial Peptides Product and Services
2.1.4 AnaSpec Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 AnaSpec Recent Developments/Updates
2.2 AMP Biotech
2.2.1 AMP Biotech Details
2.2.2 AMP Biotech Major Business
2.2.3 AMP Biotech Antimicrobial Peptides Product and Services
2.2.4 AMP Biotech Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 AMP Biotech Recent Developments/Updates
2.3 Phoenix Biotech
2.3.1 Phoenix Biotech Details
2.3.2 Phoenix Biotech Major Business
2.3.3 Phoenix Biotech Antimicrobial Peptides Product and Services
2.3.4 Phoenix Biotech Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Phoenix Biotech Recent Developments/Updates
2.4 Novabiotics
2.4.1 Novabiotics Details
2.4.2 Novabiotics Major Business
2.4.3 Novabiotics Antimicrobial Peptides Product and Services
2.4.4 Novabiotics Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Novabiotics Recent Developments/Updates
2.5 Chinese Peptide
2.5.1 Chinese Peptide Details
2.5.2 Chinese Peptide Major Business
2.5.3 Chinese Peptide Antimicrobial Peptides Product and Services
2.5.4 Chinese Peptide Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Chinese Peptide Recent Developments/Updates
2.6 Ontores
2.6.1 Ontores Details
2.6.2 Ontores Major Business
2.6.3 Ontores Antimicrobial Peptides Product and Services
2.6.4 Ontores Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Ontores Recent Developments/Updates
2.7 GenScript
2.7.1 GenScript Details
2.7.2 GenScript Major Business
2.7.3 GenScript Antimicrobial Peptides Product and Services
2.7.4 GenScript Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 GenScript Recent Developments/Updates
2.8 Hycult Biotech
2.8.1 Hycult Biotech Details
2.8.2 Hycult Biotech Major Business
2.8.3 Hycult Biotech Antimicrobial Peptides Product and Services
2.8.4 Hycult Biotech Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Hycult Biotech Recent Developments/Updates
2.9 Sunsmile
2.9.1 Sunsmile Details
2.9.2 Sunsmile Major Business
2.9.3 Sunsmile Antimicrobial Peptides Product and Services
2.9.4 Sunsmile Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Sunsmile Recent Developments/Updates
2.10 Ruixing Biotechnology
2.10.1 Ruixing Biotechnology Details
2.10.2 Ruixing Biotechnology Major Business
2.10.3 Ruixing Biotechnology Antimicrobial Peptides Product and Services
2.10.4 Ruixing Biotechnology Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Ruixing Biotechnology Recent Developments/Updates
2.11 Zhongnong Yingtai Biotechnology
2.11.1 Zhongnong Yingtai Biotechnology Details
2.11.2 Zhongnong Yingtai Biotechnology Major Business
2.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product and Services
2.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Zhongnong Yingtai Biotechnology Recent Developments/Updates
2.12 Glam Technology
2.12.1 Glam Technology Details
2.12.2 Glam Technology Major Business
2.12.3 Glam Technology Antimicrobial Peptides Product and Services
2.12.4 Glam Technology Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Glam Technology Recent Developments/Updates
2.13 ProteLight Pharmaceutical & Biotechnology
2.13.1 ProteLight Pharmaceutical & Biotechnology Details
2.13.2 ProteLight Pharmaceutical & Biotechnology Major Business
2.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product and Services
2.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 ProteLight Pharmaceutical & Biotechnology Recent Developments/Updates
3 Competitive Environment: Antimicrobial Peptides by Manufacturer
3.1 Global Antimicrobial Peptides Sales Quantity by Manufacturer (2020-2025)
3.2 Global Antimicrobial Peptides Revenue by Manufacturer (2020-2025)
3.3 Global Antimicrobial Peptides Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Antimicrobial Peptides by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Antimicrobial Peptides Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Antimicrobial Peptides Manufacturer 麻豆原创 Share in 2024
3.5 Antimicrobial Peptides 麻豆原创: Overall Company Footprint Analysis
3.5.1 Antimicrobial Peptides 麻豆原创: Region Footprint
3.5.2 Antimicrobial Peptides 麻豆原创: Company Product Type Footprint
3.5.3 Antimicrobial Peptides 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Antimicrobial Peptides 麻豆原创 Size by Region
4.1.1 Global Antimicrobial Peptides Sales Quantity by Region (2020-2031)
4.1.2 Global Antimicrobial Peptides Consumption Value by Region (2020-2031)
4.1.3 Global Antimicrobial Peptides Average Price by Region (2020-2031)
4.2 North America Antimicrobial Peptides Consumption Value (2020-2031)
4.3 Europe Antimicrobial Peptides Consumption Value (2020-2031)
4.4 Asia-Pacific Antimicrobial Peptides Consumption Value (2020-2031)
4.5 South America Antimicrobial Peptides Consumption Value (2020-2031)
4.6 Middle East & Africa Antimicrobial Peptides Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Antimicrobial Peptides Sales Quantity by Type (2020-2031)
5.2 Global Antimicrobial Peptides Consumption Value by Type (2020-2031)
5.3 Global Antimicrobial Peptides Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Antimicrobial Peptides Sales Quantity by Application (2020-2031)
6.2 Global Antimicrobial Peptides Consumption Value by Application (2020-2031)
6.3 Global Antimicrobial Peptides Average Price by Application (2020-2031)
7 North America
7.1 North America Antimicrobial Peptides Sales Quantity by Type (2020-2031)
7.2 North America Antimicrobial Peptides Sales Quantity by Application (2020-2031)
7.3 North America Antimicrobial Peptides 麻豆原创 Size by Country
7.3.1 North America Antimicrobial Peptides Sales Quantity by Country (2020-2031)
7.3.2 North America Antimicrobial Peptides Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Antimicrobial Peptides Sales Quantity by Type (2020-2031)
8.2 Europe Antimicrobial Peptides Sales Quantity by Application (2020-2031)
8.3 Europe Antimicrobial Peptides 麻豆原创 Size by Country
8.3.1 Europe Antimicrobial Peptides Sales Quantity by Country (2020-2031)
8.3.2 Europe Antimicrobial Peptides Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Antimicrobial Peptides Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Antimicrobial Peptides Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Antimicrobial Peptides 麻豆原创 Size by Region
9.3.1 Asia-Pacific Antimicrobial Peptides Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Antimicrobial Peptides Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Antimicrobial Peptides Sales Quantity by Type (2020-2031)
10.2 South America Antimicrobial Peptides Sales Quantity by Application (2020-2031)
10.3 South America Antimicrobial Peptides 麻豆原创 Size by Country
10.3.1 South America Antimicrobial Peptides Sales Quantity by Country (2020-2031)
10.3.2 South America Antimicrobial Peptides Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Antimicrobial Peptides Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Antimicrobial Peptides Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Antimicrobial Peptides 麻豆原创 Size by Country
11.3.1 Middle East & Africa Antimicrobial Peptides Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Antimicrobial Peptides Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Antimicrobial Peptides 麻豆原创 Drivers
12.2 Antimicrobial Peptides 麻豆原创 Restraints
12.3 Antimicrobial Peptides Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Antimicrobial Peptides and Key Manufacturers
13.2 Manufacturing Costs Percentage of Antimicrobial Peptides
13.3 Antimicrobial Peptides Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Antimicrobial Peptides Typical Distributors
14.3 Antimicrobial Peptides Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology
听
听
*If Applicable.
